Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Clorox Co    CLX

Delayed Quote. Delayed  - 08/29 10:00:25 pm
131.46 USD   +0.64%
08/17 CLOROX : to Present at the Barclays Global Consumer Staples Conferen..
08/11CLOROX CO : Good timing to anticipate a continuation of the trend
08/10 CLOROX : CEO takes on Chairman role; appoints new Independent Lead D..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

The Clorox Company : Refutes Silent Spring Institute's Study on Our Consumer Products

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/08/2012 | 03:26pm CEST

We have reviewed the findings of Silent Spring's study claiming some U.S. consumer products contain endocrine-disrupting and asthma-related ingredients.

Product safety is a top priority at The Clorox Company and our company guidelines prohibit using endocrine-disrupting ingredients in our products. For those household products containing fragrance ingredients some consider to be asthma related, these ingredients are present at such low concentrations they do not cause irritation or trigger asthma when used as directed.

Our highly skilled scientists evaluate each product's safety, efficacy and regulatory compliance before it makes it to store shelves. Our safety assessments begin with analysis of each of the materials that go into making the product. This includes consideration of short-term and long-term impact from all types of exposures, including incidental or accidental, and routes of exposure such as skin, eye, ingestion and inhalation. Our safety evaluation also includes the assessment of fragrances, dyes, and preservatives, and other proprietary ingredients, in our formulations.

Clorox voluntarily discloses all ingredients for our U.S. and Canadian household cleaning and disinfecting products through our industry-leading initiative, Ingredients Inside (www.IngredientsInside.com), which is available on our corporate web site and mobile platforms.

For more information on our product stewardship guidelines, visit http://www.thecloroxcompany..


share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CLOROX CO
08/25 CLOROX : Researchers Submit Patent Application, "Dual Chamber Spray Dispenser", ..
08/25 CLOROX : Patent Application Titled "Dual Chamber Spray Dispenser with a Single D..
08/17 CLOROX : to Present at the Barclays Global Consumer Staples Conference
08/16 CLOROX : DE/ MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
08/10 CLOROX : CEO takes on Chairman role; appoints new Independent Lead Director and ..
08/04 CLOROX CO /DE/ : Change in Directors or Principal Officers, Financial Statements..
08/04 CLOROX : Board Names Benno Dorer Chairman and Pamela Thomas-Graham Lead Director..
08/03DJCLOROX : Earnings Fall Amid Higher Spending
08/03DJCLOROX : Earnings Fall Amid Higher Spending
08/03 CLOROX CO /DE/ : Results of Operations and Financial Condition, Financial Statem..
More news
Sector news : Household Products - NEC
08/12DJALPHABET : Google Under Antitrust Scrutiny in South Korea
08/08 Pay up by 10 percent for Britain's top bosses in 2015, survey shows
07/29DJNEWELL BRANDS : Earnings Top Views
07/29DJRECKITT BENCKISER : Reports 18.5% Drop in First Half Profit
07/29DJRECKITT BENCKISER : Reports 18.5% Drop in First Half Profit
More sector news : Household Products - NEC
News from SeekingAlpha
08/25 88 Stock Picks For The Next 30 Years (Or More)
08/25 GOOD STOCKS ARE ALWAYS OVERVALUED : A False Safety Net
08/24 Build A Profitable Dividend Growth Investing Portfolio From Scratch (Podcast ..
08/23 The Best Quality Dividend Growth Stocks Right Now According To The Piotroski ..
08/22 CLOROX : An Expensive Yield Play
Advertisement
Financials ($)
Sales 2017 5 965 M
EBIT 2017 1 128 M
Net income 2017 715 M
Debt 2017 1 762 M
Yield 2017 2,48%
P/E ratio 2017 24,09
P/E ratio 2018 22,86
EV / Sales 2017 3,15x
EV / Sales 2018 3,04x
Capitalization 17 020 M
More Financials
Chart CLOROX CO
Duration : Period :
Clorox Co Technical Analysis Chart | CLX | US1890541097 | 4-Traders
Full-screen chart
Technical analysis trends CLOROX CO
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Average target price 128 $
Spread / Average Target -2,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Benno O. Dorer Chairman & Chief Executive Officer
Stephen M. Robb Chief Financial Officer & Executive Vice President
James E. Foster EVP-Information Technology & Product Supply
Robert W. Matschullat Lead Independent Director
Carolyn M. Ticknor Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CLOROX CO3.65%17 020
RECKITT BENCKISER GROU..18.37%68 287
UNILEVER INDONESIA TBK..--.--%26 009
NEWELL BRANDS INC22.30%25 995
CHURCH & DWIGHT CO., I..17.81%12 880
LION CORP25.51%4 126
More Results